BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

157 related articles for article (PubMed ID: 19817905)

  • 1. A follicular variant of papillary thyroid carcinoma in struma ovarii. Case report with unique molecular alterations.
    Celestino R; Magalhães J; Castro P; Triller M; Vinagre J; Soares P; Sobrinho-Simões M
    Histopathology; 2009 Oct; 55(4):482-7. PubMed ID: 19817905
    [No Abstract]   [Full Text] [Related]  

  • 2. BRAF T1799A mutation occurring in a case of malignant struma ovarii.
    Flavin R; Smyth P; Crotty P; Finn S; Cahill S; Denning K; Jinghuan Li ; O'Regan E; O'Leary J; Sheils O
    Int J Surg Pathol; 2007 Apr; 15(2):116-20. PubMed ID: 17478764
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Typical thyroid-type carcinoma arising in struma ovarii: a report of 4 cases and review of the literature.
    Roth LM; Miller AW; Talerman A
    Int J Gynecol Pathol; 2008 Oct; 27(4):496-506. PubMed ID: 18753973
    [TBL] [Abstract][Full Text] [Related]  

  • 4. BRAF in papillary thyroid carcinoma of ovary (struma ovarii).
    Schmidt J; Derr V; Heinrich MC; Crum CP; Fletcher JA; Corless CL; Nosé V
    Am J Surg Pathol; 2007 Sep; 31(9):1337-43. PubMed ID: 17721188
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Sincronous malignant struma ovarii and papillary thyroid carcinoma.
    Fernández Catalina P; Rego Iraeta A; Lorenzo Solar M; Sánchez Sobrino P
    Endocrinol Nutr; 2016; 63(7):366-7. PubMed ID: 27297016
    [No Abstract]   [Full Text] [Related]  

  • 6. RAS mutation-positive follicular variant of papillary thyroid carcinoma arising in a struma ovarii.
    Coyne C; Nikiforov YE
    Endocr Pathol; 2010 Jun; 21(2):144-7. PubMed ID: 19898969
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Struma Ovarii With Malignant Transformation and Germline KIT Mutation: A Case Report With Review of the Literature.
    Ma D; Guseva NV; Dahmoush L; Robinson RA
    Int J Gynecol Pathol; 2016 Sep; 35(5):442-7. PubMed ID: 27258816
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Novel BRAF and KRAS Mutations in Papillary Thyroid Carcinoma Arising in Struma Ovarii.
    Tan A; Stewart CJ; Garrett KL; Rye M; Cohen PA
    Endocr Pathol; 2015 Dec; 26(4):296-301. PubMed ID: 26362194
    [TBL] [Abstract][Full Text] [Related]  

  • 9. Follicular variant papillary thyroid carcinoma arising in struma ovarii.
    Boutross-Tadross O; Saleh R; Asa SL
    Endocr Pathol; 2007; 18(3):182-6. PubMed ID: 18058267
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Unilateral follicular variant of papillary thyroid carcinoma with unique KRAS mutation in struma ovarii in bilateral ovarian teratoma: a rare case report.
    Stanojevic B; Dzodic R; Saenko V; Milovanovic Z; Krstevski V; Radlovic P; Buta M; Rulic B; Todorovic L; Dimitrijevic B; Yamashita S
    BMC Cancer; 2012 Jun; 12():224. PubMed ID: 22682753
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Follicular carcinoma arising from struma ovarii. A case report.
    Limaiem F; Bouraoui S
    Pathologica; 2020 Dec; 112(4):224-228. PubMed ID: 33393527
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Thyroid carcinoma on an ovarian teratoma: a case report and review of the literature.
    Soto Moreno A; Venegas EM; Rodriguez JR; Sánchez F; Robles MJ; Martinez MA; Gonzalez D; Navarro E; Astorga R
    Gynecol Endocrinol; 2002 Jun; 16(3):207-11. PubMed ID: 12192892
    [No Abstract]   [Full Text] [Related]  

  • 13. B-RAF mutations in the etiopathogenesis, diagnosis, and prognosis of thyroid carcinomas.
    Trovisco V; Soares P; Sobrinho-Simões M
    Hum Pathol; 2006 Jul; 37(7):781-6. PubMed ID: 16784975
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Tall cell variant of papillary carcinoma arising from strumaovarii: a rare case report.
    Mardi K; Gupta N
    J Cancer Res Ther; 2013; 9(1):119-21. PubMed ID: 23575091
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Papillary thyroid carcinoma of struma ovarii.
    Griffiths AN; Jain B; Vine SJ
    J Obstet Gynaecol; 2004 Jan; 24(1):92-3. PubMed ID: 14675996
    [No Abstract]   [Full Text] [Related]  

  • 16. Familial non-medullary thyroid carcinoma (FNMTC): analysis of fPTC/PRN, NMTC1, MNG1 and TCO susceptibility loci and identification of somatic BRAF and RAS mutations.
    Cavaco BM; Batista PF; Martins C; Banito A; do Rosário F; Limbert E; Sobrinho LG; Leite V
    Endocr Relat Cancer; 2008 Mar; 15(1):207-15. PubMed ID: 18310288
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Malignant struma ovarii: report of a case and review of the literature.
    Kostoglou-Athanassiou I; Lekka-Katsouli I; Gogou L; Papagrigoriou L; Chatonides I; Kaldrymides P
    Horm Res; 2002; 58(1):34-8. PubMed ID: 12169779
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Struma Ovarii with a focus of papillary thyroid cancer: a case report and review of the literature.
    Makani S; Kim W; Gaba AR
    Gynecol Oncol; 2004 Sep; 94(3):835-9. PubMed ID: 15350384
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Evidence that one subset of anaplastic thyroid carcinomas are derived from papillary carcinomas due to BRAF and p53 mutations.
    Quiros RM; Ding HG; Gattuso P; Prinz RA; Xu X
    Cancer; 2005 Jun; 103(11):2261-8. PubMed ID: 15880523
    [TBL] [Abstract][Full Text] [Related]  

  • 20. BRAF and K-RAS mutation in a Greek papillary and medullary thyroid carcinoma cohort.
    Goutas N; Vlachodimitropoulos D; Bouka M; Lazaris AC; Nasioulas G; Gazouli M
    Anticancer Res; 2008; 28(1A):305-8. PubMed ID: 18383861
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 8.